Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Messeri"'
Autor:
Irene Attucci, Sofia Pilerci, Maria Messeri, Ludovica Pengue, Giulia Tomasino, Leonardo Caroti, Alessandro M. Vannucchi, Elisabetta Antonioli
Publikováno v:
Cancer Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)
ABSTRACTBackgroundThrombotic microangiopathy (TMA) is a pathological syndrome characterized by a combination of three key features: microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ damage, primarily affecting the kidneys. There a
Externí odkaz:
https://doaj.org/article/e2f4fd4560f144f5a0448599655f8902
Autor:
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, Gabriele Buda, Alessandro Gozzetti, Veronica Candi, Federico Simonetti, Maria Livia Del Giudice, Sara Ciofini, Michela Staderini, Sara Grammatico, Alessandra Buzzichelli, Maria Messeri, Monica Bocchia, Sara Galimberti, Alessandro M. Vannucchi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCarfilzomib, a potent, irreversible, selective proteasome inhibitor has demonstrated consistent results in relapsed/refractory multiple myeloma (RRMM) combined with lenalidomide and dexamethasone (KRd). No prospective studies are yet avai
Externí odkaz:
https://doaj.org/article/0187b91cd2a6449081286e4dd3695ef6
Autor:
Francesco Cappelli, Federico Perfetto, Michela Staderini, Marco Allinovi, Irene Attucci, Sofia Pilerci, Alberto Bosi, Chiara Nozzoli, Elisabetta Antonioli, Maria Messeri, Alessandra Buzzichelli
Publikováno v:
Leukemialymphoma. 61(13)
In recent years, the clinical outcome of multiple myeloma (MM) patients has improved due to the introduction of several new agents and of immunotherapy. The combination of novel drugs has allowed i...
Autor:
Alessandra Buzzichelli, Maria Messeri, Alberto Bosi, Enrico Attardi, Chiara Nozzoli, Michela Staderini, Elisabetta Antonioli
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e141